Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3025-3030

  Demaria, S ^a   Volm, M D ^a   Shapiro, R L ^a   Yee, H T ^a   Oratz, R ^a   Formenti, S C ^a   Muggia, F ^a   Symmans, W F ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT PLANNING; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD8; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MEMBRANE PROTEINS; MIDDLE AGED; PACLITAXEL; POLY(A)-BINDING PROTEINS; PROTEINS; RNA-BINDING PROTEINS; TREATMENT OUTCOME;

EID: 0034796870     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer
2. Pathological assessment of response to induction chemotherapy in breast cancer
3. Primary chemotherapy in operable breast cancer. Eight-year experience at the Milan Cancer Institute
4. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
5. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
6. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes
7. Dendritic cells: A novel therapeutic modality
8. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
9. Cutting edge: Bystander apoptosis triggers dendritic cell maturation antigen-presenting function
10. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel
11. Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine needle aspiration: Implications for early prediction of breast cancer response to neoadjuvant treatment
12. The immunology and immunotherapy of breast cancer: An update
13. Functional analysis of mononuclear cell infiltrating into tumors: Lysis of autologous human tumor cells by cultured infiltrating lymphocytes
14. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer
16. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: Characterization and antigen-specific activation
17. Structural representations of tumor host relationship in mammary carcinoma: Biologic and prognostic significance
18. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: An immunoperoxidase study with anti-human T- and B-cell sera
19. Lymphocyte infiltrates as a prognostic variable in female breast cancer
20. Host defense and survival in patients with lung carcinoma
21. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
22. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
23. The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue
24. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy
25. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma
26. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer
27. Neo-adjuvant paclitaxel for locally advanced breast cancer: Preliminary results
28. Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow-up
29. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast
30. Original p53 status predicts for pathological response in locally advanced breast cancer patients treated pre-operatively with continuous infusion 5-fluorouracil and radiation therapy
31. Concurrent paclitaxel and radiation therapy for breast cancer
32. Remission rates following preoperative chemotherapy and radiation therapy in patients with breast cancer
33. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
34. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide
35. Effects of paclitaxel on cytokine synthesis by unprimed human monocytes. T lymphocytes, and breast cancer cells
36. Flt3-Ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer
37. Decreased antigen presentation by dendritic cells in patients with breast cancer
38. Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer
39. Prolonged neoadjuvant treatment in locally advanced tumors: A novel concept based on biological considerations